Drug Pipeline Wins State Street Over on HealthcareDrug Pipeline Wins State Street Over on HealthcareDrug Pipeline Wins State Street Over on Healthcare 

State Street Investment Management is turning positive on healthcare stocks after nearly a year of caution. The firm’s Q3 2026 sector outlook upgraded healthcare from neutral to positive. That marks the sector’s return to State Street’s list of favored trades. Key Takeaways: Healthcare earnings could jump to 19.3% growth by 2027. Institutional investors remain underweight […]
The post Drug Pipeline Wins State Street Over on Healthcare appeared first on ETF Trends.